• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Irish-based pharma firms now have stricter marketing code

Irish-based pharma firms now have stricter marketing code

January 20, 2012
CenterWatch Staff

Pharmaceutical companies in Ireland may no longer use well-known entertainment or other leisure activity venues to promote their products to health professionals, new guidelines have stated.

According to a report in The Irish Times, the updated code of marketing practice for the industry has strict criteria for promoting new drugs to health professionals. Corporate activities involving sporting, entertainment or social events must not be extended to healthcare professionals. And promotional meetings may not be held to coincide with sporting or entertainment events.

The code also states companies should not hold events abroad unless absolutely necessary and foreign professionals are also attending. Travel expenses are not to be paid for spouses or partners unless those persons are also healthcare professionals involved in the field. Companies can, however, provide corporate hospitality if it is a bona fide charity event.

It states health professionals should not receive more than four medical samples of a particular new medicine per year. Sampling cannot extend to any mind-altering drugs such as sedatives or anti-depressants. And pharmaceutical companies must declare in clear language any support they give to patients’ associations.

The guidelines are to ensure Irish-based pharmaceutical companies comply with the updated European Federation of Pharmaceutical Industries and Associations regulations.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing